Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.
Del Pozo R, Blanco I, Hernández-González I, López-Meseguer M, López-Reyes R, Lázaro-Salvador M, Elías-Hernández T, Álvarez-Vega P, Pérez-Peñate GM, Martínez-Meñaca A, Bedate P, Escribano-Subias P; REHAP investigators. Del Pozo R, et al. Int J Cardiol. 2019 Jan 15;275:158-164. doi: 10.1016/j.ijcard.2018.10.012. Epub 2018 Oct 5. Int J Cardiol. 2019. PMID: 30316648
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.
Mora D, Mateo J, Nieto JA, Bikdeli B, Yamashita Y, Barco S, Jimenez D, Demelo-Rodriguez P, Rosa V, Yoo HHB, Sadeghipour P, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica (RIETE) Investigators. Mora D, et al. Br J Haematol. 2023 Jun;201(5):971-981. doi: 10.1111/bjh.18737. Epub 2023 Mar 21. Br J Haematol. 2023. PMID: 36942630
Chronic thromboembolic pulmonary hypertension in Spain: a decade of change.
Martínez-Santos P, Velázquez-Martín MT, Barberá JA, Fernández Pérez C, López-Meseguer M, López-Reyes R, Martínez-Meñaca A, Lara-Padrón A, Domingo-Morera JA, Blanco I, Escribano-Subías P; REHAP investigators. Martínez-Santos P, et al. Rev Esp Cardiol (Engl Ed). 2021 May;74(5):384-392. doi: 10.1016/j.rec.2020.06.006. Epub 2020 Jul 9. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32654945 English, Spanish.
From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
Martínez Meñaca A, Blanco Vich I, López Meseguer M, López Reyes R, Bedate Díaz P, Elías Hernández T, Fernández-Cuesta Peñafiel I, Fernández G, Álvez Liste A, Escribano Subías P. Martínez Meñaca A, et al. Adv Ther. 2021 Apr;38(4):1860-1875. doi: 10.1007/s12325-021-01625-w. Epub 2021 Mar 6. Adv Ther. 2021. PMID: 33675523
Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial.
Jiménez D, Agustí A, Tabernero E, Jara-Palomares L, Hernando A, Ruiz-Artacho P, Pérez-Peñate G, Rivas-Guerrero A, Rodríguez-Nieto MJ, Ballaz A, Agüero R, Jiménez S, Calle-Rubio M, López-Reyes R, Marcos-Rodríguez P, Barrios D, Rodríguez C, Muriel A, Bertoletti L, Couturaud F, Huisman M, Lobo JL, Yusen RD, Bikdeli B, Monreal M, Otero R; SLICE Trial Group. Jiménez D, et al. JAMA. 2021 Oct 5;326(13):1277-1285. doi: 10.1001/jama.2021.14846. JAMA. 2021. PMID: 34609451 Free PMC article. Clinical Trial.
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Mar 28;12(1):5289. doi: 10.1038/s41598-022-09353-z. Sci Rep. 2022. PMID: 35347225 Free PMC article.
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Guillén-Del-Castillo A, Meseguer ML, Fonollosa-Pla V, Giménez BS, Colunga-Argüelles D, Revilla-López E, Rubio-Rivas M, Ropero MJC, Argibay A, Barberá JA, Salas XP, Meñaca AM, Vuelta ABM, Padrón AL, Comet LS, Morera JAD, González-Echávarri C, Mombiela T, Ortego-Centeno N, González MM, Tolosa-Vilella C, Blanco I, Subías PE, Simeón-Aznar CP; RESCLE Consortium; REHAP Consortium. Guillén-Del-Castillo A, et al. Sci Rep. 2022 Jul 28;12(1):12947. doi: 10.1038/s41598-022-17525-0. Sci Rep. 2022. PMID: 35902683 Free PMC article. No abstract available.
87 results